NCT02983591View on ClinicalTrials.gov

Effect of Misoprostol in Reducing Post Partum Hemorrhage After Labor Induction by Oxytocin

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 30, 2017

Study Completion Date

December 30, 2017

Conditions
Prevention of Post Partum Hemorrhage After Labor Induction
Interventions
DRUG

Misoprostol after delivery

Patients will receive 1000 mcg Misoprostol per rectum

DRUG

Oxytocin after delivery

Patients will receive 20 units oxytocin intravenously in one liter of Lactated Ringer solution at a rate of 150ml/h

DRUG

Oxytocin before delivery

All patients will receive oxytocin 0.5-1 milliUnit/min IV, titrated to 1-2 milliUnit/min every 15-60 min before delivery to induce labor

Trial Locations (1)

Unknown

Makassed General Hospital, Beirut

All Listed Sponsors
lead

Makassed General Hospital

OTHER

NCT02983591 - Effect of Misoprostol in Reducing Post Partum Hemorrhage After Labor Induction by Oxytocin | Biotech Hunter | Biotech Hunter